MedTrace Logo

Low Anterior Resection Syndrome After Rectum Resection for Rectal Carcinoma.

NCT05506111 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-08-19

No results posted yet for this study

Summary

The ACO-ASSO (Austrian Society of Surgical Oncology) colorectal group and Austrian Working Group for Coloproctology present the LARS Austria study. It is a prospective, multicenter observational study. The primary objective of this study is to collect information about LARS (LARS score) and QoL (EORTC -CR29) in patients with non-metastatic rectal cancer who received therapy. As a secondary objective, the impact of radiotherapy on the occurrence of LARS will be investigated.

Conditions

  • Low Anterior Resection Syndrome
  • Quality of Life
  • Incontinence

Sponsors & Collaborators

  • Department of Surgery Hospital of St. John of God, Graz

    collaborator UNKNOWN

  • Medical University of Vienna

    collaborator OTHER

  • Paracelsus Medical University

    lead OTHER

Principal Investigators

  • Stefan Riss, Prof. Dr. · Medical University Wien, Department of Surgery

  • Felix Aigner, Prof. Dr. · Department of Surgery Hospital of St. John of God, Graz

  • Jaroslav Presl, Dr. · Paracelsus Medical University Salzburg, Department of Surgery

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-18
Primary Completion
2024-07-31
Completion
2024-07-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05506111 on ClinicalTrials.gov